These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33439096)

  • 1. The global challenge of treating disseminated LCH.
    Gulati N
    Pediatr Hematol Oncol; 2020 Nov; 37(8):653-655. PubMed ID: 33439096
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk organ + LCH gets the one-two punch?
    Stine KC
    Blood; 2015 Sep; 126(12):1399-400. PubMed ID: 26384280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage therapy with 2-chlorodeoxyadenosine for refractory and relapsed pediatric Langerhans cell histiocytosis: an updated nationwide survey in Japan.
    Taniguchi M; Sakamoto K; Shioda Y; Doi T; Kudo K; Fujino H; Kudo K; Morimoto A
    Int J Hematol; 2021 Mar; 113(3):461-463. PubMed ID: 33564966
    [No Abstract]   [Full Text] [Related]  

  • 4. Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study.
    Donadieu J; Bernard F; van Noesel M; Barkaoui M; Bardet O; Mura R; Arico M; Piguet C; Gandemer V; Armari Alla C; Clausen N; Jeziorski E; Lambilliote A; Weitzman S; Henter JI; Van Den Bos C;
    Blood; 2015 Sep; 126(12):1415-23. PubMed ID: 26194764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal involvement in disseminated Langerhans cell histiocytosis (LCH) with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine.
    Choi SW; Bangaru BS; Wu CD; Finlay JL
    J Pediatr Hematol Oncol; 2003 Jun; 25(6):503-6. PubMed ID: 12794533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofarabine salvage therapy for refractory high-risk langerhans cell histiocytosis.
    Abraham A; Alsultan A; Jeng M; Rodriguez-Galindo C; Campbell PK
    Pediatr Blood Cancer; 2013 Jun; 60(6):E19-22. PubMed ID: 23255383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clofarabine in refractory Langerhans cell histiocytosis.
    Rodriguez-Galindo C; Jeng M; Khuu P; McCarville MB; Jeha S
    Pediatr Blood Cancer; 2008 Nov; 51(5):703-6. PubMed ID: 18623218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cladribine for 13 cases refractory high-risk children Langerhans cell histiocytosis].
    Hu T; Liu R; Li J; Cao J; Zhang L; Li J; Fan W; Zhong D; Shi X
    Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):985-9. PubMed ID: 25417874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Langerhans cell histiocytosis in children: from the bench to bedside for an updated therapy.
    Aricò M
    Br J Haematol; 2016 Jun; 173(5):663-70. PubMed ID: 26913480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group].
    Adam Z; Szturz P; Pour L; Krejčí M; Zahradová L; Tomíška M; Král Z; Koukalová R; Rehák Z; Mayer J
    Vnitr Lek; 2012 Jun; 58(6):455-65. PubMed ID: 22913238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clofarabine monotherapy in two patients with refractory Langerhans cell histiocytosis.
    Irie M; Nakano T; Katayama S; Suzuki T; Moriya K; Watanabe Y; Suzuki N; Saitoh-Nanjyo Y; Onuma M; Rikiishi T; Niizuma H; Sasahara Y; Kure S
    Cancer Rep (Hoboken); 2022 Aug; 5(8):e1579. PubMed ID: 34725963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cladribine treatment of repeatedly-relapsed Langerhans cell histiocytosis: a case report and literature review].
    Yao X; Ying H; Weihong Z; Qing S; Xintian L
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):296-9. PubMed ID: 26182506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment with 2-chlorodeoxyadenosine of refractory pediatric Langerhans cell histiocytosis with initial involvement of the gastrointestinal tract.
    Mayumi A; Imamura T; Sakamoto K; Ota T; Osone S; Usami I; Hosoi H
    Int J Hematol; 2019 Dec; 110(6):756-762. PubMed ID: 31350665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory LCH With Secondary Intracranial PNET: A Case Report and Review of Literature.
    Chayapathi V; Mahajan A; Kalra M
    J Pediatr Hematol Oncol; 2018 Mar; 40(2):e117-e120. PubMed ID: 28859038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Langerhans cell histiocytosis with central nervous system involvement: follow-up by FDG-PET during treatment with cladribine.
    Büchler T; Cervinek L; Belohlavek O; Kantorova I; Mechl M; Nebesky T; Vorlicek J; Adam Z
    Pediatr Blood Cancer; 2005 Mar; 44(3):286-8. PubMed ID: 15481071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
    Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
    Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy and safety of 2CdA (cladribine) in extra-pulmonary adult-onset Langerhans cell histiocytosis: analysis of 23 cases from the French Histiocytosis Group and systematic literature review.
    Néel A; Artifoni M; Fontenoy AM; Tessoulin B; Lorillon G; Cohen-Aubart F; Haroche J; Genereau T; de Menthon M; Guillevin L; Maillard H; Kahn JE; Hermine O; Araujo C; Dromer C; Jullien D; Hamidou M; Donadieu J; Tazi A
    Br J Haematol; 2020 Jun; 189(5):869-878. PubMed ID: 32191819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug therapy for the treatment of Langerhans cell histiocytosis.
    McClain KL
    Expert Opin Pharmacother; 2005 Nov; 6(14):2435-41. PubMed ID: 16259575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Langerhans cell histiocytosis in children: History, classification, pathobiology, clinical manifestations, and prognosis.
    Krooks J; Minkov M; Weatherall AG
    J Am Acad Dermatol; 2018 Jun; 78(6):1035-1044. PubMed ID: 29754885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seventy-nine-year-old man with Langerhans cell histiocytosis treated with cladribine.
    Black A; Bershow A; Allen PS; Crowson AN
    J Am Acad Dermatol; 2011 Sep; 65(3):681-683. PubMed ID: 21839340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.